Selected Publications
Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK.: Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome. J Am Acad Dermatol. 92 (3): 634-636,2025.
Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK.: Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome. J Am Acad Dermatol : 2024.
Villasenor-Park J, Chung J, Kim EJ: Cutaneous B-cell Lymphomas/Cutaneous Oncology Hematology Oncology Clinics 38 (5): 1111,2024.
Silva GS, Kim EJ, Barta SK, Chung J: Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature Expert Rev Anticancer Ther 24 (9): 819-827,2024.
Asare C, Chen J, Ottevanger R, Scarisbrick J, Olsen EA, Tawa M, Thornton S, Kim E, Khan N, Larocca C, Shinohara MM.: Systematic literature review to identify patient-reported outcome measures for patients with cutaneous T-cell lymphoma.
International Dermatology Outcomes Measures 11th Annual Meeting, Washington D.C. : 2024.
Rastogi S, Kim EJ, Gelfand JM, Loren AW, Baumrin E: Chronic graft-versus-host disease-associated muscle cramps: severity and response to immunomodulatory therapies
Transplant Cell Ther 24 : 2024.
Weiner DW, Rastogi S, Lewis DJ, Cohen L, Choi S, Vittorio CC, Haun PL, Samimi SS, Villasenor-Park J, Bhansali RS, Chong EA, Landsburg DJ, Nasta SD, Schuster, Svoboda J, Kim EJ, Rook AH, Barta SK.: Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma Dermatologic Therapy : 2023.
Bagot M, Kim YH, Geskin LJ, Ortiz-Romero P, Kim E, Mehta-Shah N, Dereure O, Oro S, Beylot-barry M, Dalle S, Jacobsen E, Lansigan F, Ram-Wolff C, Khodadoust MS, Battistella M, Gru A, Moins-Teisserenc H, Zinzani PL, Viott J, Paiva C, Muller M, Porcu P.: Lacutumab in Patients with Relapsed and Refractory Sezary Syndrome: Results from the Tellomak Phase 2 Trial American Society of Hematology Annual Meeting, San Diego, CA : 2023.
Polgione B, Alexander-Savino CV, Kim EJ, Mangold AR, Desimone J, Wong H, Rumage AT, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH.: HyBryte™ Use in Early-Stage Cutaneous T-cell Lymphoma
Front Drug Discov 3 : 2023.
Gunter S and Kim EJ: Impact of Guidelines from the 2011 International Society for Cutaneous Lymphomas on Registered and Pivotal Clinical Trials in Cutaneous T-Cell Lymphoma: A Retrospective Cohort Study J Invest Dermatol 23 : 3038-5.,2023.
Academic Contact Information
Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Room 721, 7th Floor - South Tower
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-662-2737
Patient appointments: 800-789-7366